Guest: John LaMattina, Senior Partner, Pure Tech Ventures Bio and Contact Info Listen (6:27) Comparing drug approvals: 2014 with 1996 Listen (7:10) More rational drug development?
'A Good Year' with John LaMattina
Guest: John LaMattina, Senior Partner, Pure Tech Ventures Bio and Contact Info Listen (6:27) Comparing drug approvals: 2014 with 1996 Listen (7:10) More rational drug development?